• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管细胞外超氧化物歧化酶在高血压中的作用。

Role of vascular extracellular superoxide dismutase in hypertension.

机构信息

Division of Clinical Pharmacology, 536 Robinson Research Building, Vanderbilt University School of Medicine, Nashville, TN 37232-6602, USA.

出版信息

Hypertension. 2011 Aug;58(2):232-9. doi: 10.1161/HYPERTENSIONAHA.111.172718. Epub 2011 Jul 5.

DOI:10.1161/HYPERTENSIONAHA.111.172718
PMID:21730294
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3376381/
Abstract

Previous studies indicate that superoxide is important in the modulation of blood pressure but have not specifically identified the cell types or organs involved. We created mice with loxP sites flanking the extracellular superoxide dismutase (SOD3) gene. These mice were crossed with mice expressing inducible Cre-recombinase driven by the smooth muscle myosin heavy chain promoter allowing tissue-specific deletion of SOD3. Deletion of SOD3 increased vascular superoxide and reduced vascular NO levels as detected by electron spin resonance. Despite these changes in NO and superoxide, we did not observe increases in vascular inflammation caused by angiotensin II. Moreover, deletion of vascular SOD3 did not augment hypertension in response to angiotensin II. In additional studies, we also deleted SOD3 from the circumventricular organs by intracerebroventricular injection of an adenovirus encoding Cre-recombinase. Although this raised blood pressure and augmented the hypertension caused by angiotensin II, these responses were not further increased by vascular deletion of SOD3. These data suggest that the extracellular superoxide dismutase in vascular smooth muscle is not involved in the genesis of angiotensin II-induced hypertension and further emphasize the role of central SOD3 in the modulation of blood pressure.

摘要

先前的研究表明超氧化物在血压调节中很重要,但并未具体确定涉及的细胞类型或器官。我们创建了带有loxP 位点侧翼的细胞外超氧化物歧化酶(SOD3)基因的小鼠。这些小鼠与表达由平滑肌肌球蛋白重链启动子驱动的诱导型 Cre 重组酶的小鼠交配,允许 SOD3 的组织特异性缺失。SOD3 的缺失增加了血管中的超氧化物并降低了血管中的 NO 水平,这是通过电子自旋共振检测到的。尽管 NO 和超氧化物发生了这些变化,但我们没有观察到血管炎症因血管紧张素 II 而增加。此外,血管 SOD3 的缺失也不会增强血管紧张素 II 引起的高血压。在其他研究中,我们还通过脑室内注射编码 Cre 重组酶的腺病毒从脑周围器官中删除 SOD3。尽管这会升高血压并增强血管紧张素 II 引起的高血压,但血管 SOD3 的缺失并没有进一步增加这些反应。这些数据表明血管平滑肌中的细胞外超氧化物歧化酶不参与血管紧张素 II 诱导的高血压的发生,并进一步强调了中枢 SOD3 在血压调节中的作用。

相似文献

1
Role of vascular extracellular superoxide dismutase in hypertension.血管细胞外超氧化物歧化酶在高血压中的作用。
Hypertension. 2011 Aug;58(2):232-9. doi: 10.1161/HYPERTENSIONAHA.111.172718. Epub 2011 Jul 5.
2
Induction of hypertension and peripheral inflammation by reduction of extracellular superoxide dismutase in the central nervous system.中枢神经系统中超氧化物歧化酶减少诱导高血压和外周炎症。
Hypertension. 2010 Feb;55(2):277-83, 6p following 283. doi: 10.1161/HYPERTENSIONAHA.109.142646. Epub 2009 Dec 14.
3
Role of copper transport protein antioxidant 1 in angiotensin II-induced hypertension: a key regulator of extracellular superoxide dismutase.铜转运蛋白抗氧化 1 在血管紧张素 II 诱导的高血压中的作用:细胞外超氧化物歧化酶的关键调节因子。
Hypertension. 2012 Aug;60(2):476-86. doi: 10.1161/HYPERTENSIONAHA.111.189571. Epub 2012 Jul 2.
4
Role of Menkes ATPase in angiotensin II-induced hypertension: a key modulator for extracellular superoxide dismutase function.门克斯ATP酶在血管紧张素II诱导的高血压中的作用:细胞外超氧化物歧化酶功能的关键调节因子。
Hypertension. 2008 Nov;52(5):945-51. doi: 10.1161/HYPERTENSIONAHA.108.116467. Epub 2008 Sep 2.
5
Angiotensin II type 1A receptors in vascular smooth muscle cells do not influence aortic remodeling in hypertension.血管平滑肌细胞中的血管紧张素 II 型 1A 受体不会影响高血压中的主动脉重塑。
Hypertension. 2011 Mar;57(3):577-85. doi: 10.1161/HYPERTENSIONAHA.110.165274. Epub 2011 Jan 17.
6
Role of extracellular superoxide dismutase in hypertension.细胞外超氧化物歧化酶在高血压中的作用。
Hypertension. 2006 Sep;48(3):473-81. doi: 10.1161/01.HYP.0000235682.47673.ab. Epub 2006 Jul 24.
7
HDAC6 inhibition upregulates endothelial SOD3 expression via Sp1 acetylation and attenuates angiotensin II-induced hypertension.组蛋白去乙酰化酶6抑制通过Sp1乙酰化上调内皮型超氧化物歧化酶3表达并减轻血管紧张素II诱导的高血压。
FEBS J. 2025 May;292(10):2624-2644. doi: 10.1111/febs.70026. Epub 2025 Feb 16.
8
Superoxide dismutase 1 limits renal microvascular remodeling and attenuates arteriole and blood pressure responses to angiotensin II via modulation of nitric oxide bioavailability.超氧化物歧化酶 1 通过调节一氧化氮生物利用度来限制肾脏微血管重塑,并减轻血管紧张素 II 引起的小动脉和血压反应。
Hypertension. 2010 Nov;56(5):907-13. doi: 10.1161/HYPERTENSIONAHA.110.159301. Epub 2010 Sep 27.
9
Protective role of vascular smooth muscle cell PPARγ in angiotensin II-induced vascular disease.血管平滑肌细胞 PPARγ 在血管紧张素Ⅱ诱导的血管疾病中的保护作用。
Cardiovasc Res. 2013 Mar 1;97(3):562-70. doi: 10.1093/cvr/cvs362. Epub 2012 Dec 17.
10
Copper transporter ATP7A protects against endothelial dysfunction in type 1 diabetic mice by regulating extracellular superoxide dismutase.铜转运蛋白 ATP7A 通过调节细胞外超氧化物歧化酶保护 1 型糖尿病小鼠的血管内皮功能障碍。
Diabetes. 2013 Nov;62(11):3839-50. doi: 10.2337/db12-1228. Epub 2013 Jul 24.

引用本文的文献

1
Renoprotective and antihypertensive mechanism of action of Clinacanthus nutans bioactive polysaccharides by suppression of reactive oxygen species/ nuclear factor/ matrix metalloproteinase (ROS/NF-ΚB/MMP-9) and upregulation of endothelial nitric oxide synthase/nitric oxide (eNOS/NO) pathways.通过抑制活性氧/核因子/基质金属蛋白酶(ROS/NF-κB/MMP-9)以及上调内皮型一氧化氮合酶/一氧化氮(eNOS/NO)途径,爵床生物活性多糖的肾脏保护和降压作用机制
J Mol Histol. 2025 Jun 28;56(4):209. doi: 10.1007/s10735-025-10481-9.
2
Crucial Interactions between Altered Plasma Trace Elements and Fatty Acids Unbalance Ratio to Management of Systemic Arterial Hypertension in Diabetic Patients: Focus on Endothelial Dysfunction.糖尿病患者系统性动脉高血压治疗中,改变的血浆微量元素与脂肪酸失衡比值与关键相互作用:聚焦于血管内皮功能障碍。
Int J Mol Sci. 2024 Aug 27;25(17):9288. doi: 10.3390/ijms25179288.
3

本文引用的文献

1
Role of increased guanosine triphosphate cyclohydrolase-1 expression and tetrahydrobiopterin levels upon T cell activation.T 细胞活化时鸟苷三磷酸环化水解酶-1 表达增加和四氢生物蝶呤水平升高的作用。
J Biol Chem. 2011 Apr 22;286(16):13846-51. doi: 10.1074/jbc.M110.191023. Epub 2011 Feb 22.
2
Lymphocyte responses exacerbate angiotensin II-dependent hypertension.淋巴细胞反应加剧血管紧张素 II 依赖性高血压。
Am J Physiol Regul Integr Comp Physiol. 2010 Apr;298(4):R1089-97. doi: 10.1152/ajpregu.00373.2009. Epub 2010 Feb 10.
3
Induction of hypertension and peripheral inflammation by reduction of extracellular superoxide dismutase in the central nervous system.
Immune Mechanisms in Hypertension.高血压的免疫机制。
Hypertension. 2024 Aug;81(8):1659-1674. doi: 10.1161/HYPERTENSIONAHA.124.21355. Epub 2024 Jun 17.
4
Modulating Nitric Oxide: Implications for Cytotoxicity and Cytoprotection.调节一氧化氮:对细胞毒性和细胞保护的影响
Antioxidants (Basel). 2024 Apr 23;13(5):504. doi: 10.3390/antiox13050504.
5
Superoxide dismutase as a protective factor for microalbuminuria in hypertensive patients.超氧化物歧化酶作为高血压患者微量白蛋白尿的保护因素。
Sci Rep. 2022 Nov 28;12(1):20432. doi: 10.1038/s41598-022-24804-3.
6
The L-shaped association between superoxide dismutase levels and blood pressure in older Chinese adults: community-based, cross-sectional study.中国老年人群中超氧化物歧化酶水平与血压的L型关联:基于社区的横断面研究
J Geriatr Cardiol. 2022 Jan 28;19(1):71-82. doi: 10.11909/j.issn.1671-5411.2022.01.002.
7
Deletion of Superoxide Dismutase 1 Blunted Inflammatory Aortic Remodeling in Hypertensive Mice under Angiotensin II Infusion.超氧化物歧化酶1缺失减轻了血管紧张素II输注下高血压小鼠的炎症性主动脉重塑。
Antioxidants (Basel). 2021 Mar 16;10(3):471. doi: 10.3390/antiox10030471.
8
Placental superoxide dismutase 3 mediates benefits of maternal exercise on offspring health.胎盘超氧化物歧化酶 3 介导母体运动对后代健康的益处。
Cell Metab. 2021 May 4;33(5):939-956.e8. doi: 10.1016/j.cmet.2021.03.004. Epub 2021 Mar 25.
9
Extracellular Superoxide Dismutase, the Endothelial Basement Membrane, and the WNT Pathway: New Players in Vascular Normalization and Tumor Infiltration by T-Cells.细胞外超氧化物歧化酶、内皮基底膜和 WNT 通路:T 细胞血管正常化和浸润肿瘤的新参与者。
Front Immunol. 2020 Oct 30;11:579552. doi: 10.3389/fimmu.2020.579552. eCollection 2020.
10
Genetic polymorphisms associated with reactive oxygen species and blood pressure regulation.与活性氧和血压调节相关的遗传多态性。
Pharmacogenomics J. 2019 Aug;19(4):315-336. doi: 10.1038/s41397-019-0082-4. Epub 2019 Feb 6.
中枢神经系统中超氧化物歧化酶减少诱导高血压和外周炎症。
Hypertension. 2010 Feb;55(2):277-83, 6p following 283. doi: 10.1161/HYPERTENSIONAHA.109.142646. Epub 2009 Dec 14.
4
Renal proximal tubular reabsorption is reduced in adult spontaneously hypertensive rats: roles of superoxide and Na+/H+ exchanger 3.成年自发性高血压大鼠的肾近端小管重吸收减少:超氧化物和Na+/H+交换体3的作用
Hypertension. 2009 Dec;54(6):1291-7. doi: 10.1161/HYPERTENSIONAHA.109.134783. Epub 2009 Oct 5.
5
Attenuation of angiotensin II-induced vascular dysfunction and hypertension by overexpression of Thioredoxin 2.硫氧还蛋白2过表达减轻血管紧张素II诱导的血管功能障碍和高血压
Hypertension. 2009 Aug;54(2):338-44. doi: 10.1161/HYPERTENSIONAHA.108.127928. Epub 2009 Jun 8.
6
Loss of extracellular superoxide dismutase leads to acute lung damage in the presence of ambient air: a potential mechanism underlying adult respiratory distress syndrome.细胞外超氧化物歧化酶的缺失在存在环境空气的情况下会导致急性肺损伤:这是成人呼吸窘迫综合征潜在的发病机制。
Am J Pathol. 2008 Oct;173(4):915-26. doi: 10.2353/ajpath.2008.080119. Epub 2008 Sep 11.
7
L-4F treatment reduces adiposity, increases adiponectin levels, and improves insulin sensitivity in obese mice.L-4F治疗可降低肥胖小鼠的肥胖程度,提高脂联素水平,并改善胰岛素敏感性。
J Lipid Res. 2008 Aug;49(8):1658-69. doi: 10.1194/jlr.M800046-JLR200. Epub 2008 Apr 19.
8
Glutathione peroxidase-1 plays a major role in protecting against angiotensin II-induced vascular dysfunction.谷胱甘肽过氧化物酶-1在预防血管紧张素II诱导的血管功能障碍中起主要作用。
Hypertension. 2008 Apr;51(4):872-7. doi: 10.1161/HYPERTENSIONAHA.107.103572. Epub 2008 Feb 25.
9
G12-G13-LARG-mediated signaling in vascular smooth muscle is required for salt-induced hypertension.血管平滑肌中G12-G13-LARG介导的信号传导是盐诱导性高血压所必需的。
Nat Med. 2008 Jan;14(1):64-8. doi: 10.1038/nm1666. Epub 2007 Dec 16.
10
Extracellular superoxide dismutase deficiency exacerbates pressure overload-induced left ventricular hypertrophy and dysfunction.细胞外超氧化物歧化酶缺乏会加剧压力超负荷诱导的左心室肥厚和功能障碍。
Hypertension. 2008 Jan;51(1):19-25. doi: 10.1161/HYPERTENSIONAHA.107.098186. Epub 2007 Nov 12.